Viagra Super Active: Enhanced Bioavailability for Rapid Erection Support

Viagra

Viagra

Viagra is often the first treatment tried for erectile dysfunction in men and pulmonary arterial hypertension.
Product dosage: 100mg
Package (num)Per pillPriceBuy
10$4.50$45.00 (0%)🛒 Add to cart
20$2.75$90.00 $55.00 (39%)🛒 Add to cart
30$2.17$135.00 $65.00 (52%)🛒 Add to cart
60$1.50$270.00 $90.00 (67%)🛒 Add to cart
90$1.44$405.00 $130.00 (68%)🛒 Add to cart
120$1.33$540.00 $160.00 (70%)🛒 Add to cart
180$1.22$810.00 $220.00 (73%)🛒 Add to cart
270$1.11$1215.00 $300.00 (75%)🛒 Add to cart
360
$1.00 Best per pill
$1620.00 $360.00 (78%)🛒 Add to cart
Product dosage: 25mg
Package (num)Per pillPriceBuy
20$2.00$40.00 (0%)🛒 Add to cart
30$1.50$60.00 $45.00 (25%)🛒 Add to cart
60$0.92$120.00 $55.00 (54%)🛒 Add to cart
90$0.67$180.00 $60.00 (67%)🛒 Add to cart
120$0.58$240.00 $70.00 (71%)🛒 Add to cart
180$0.44$360.00 $80.00 (78%)🛒 Add to cart
270$0.31$540.00 $85.00 (84%)🛒 Add to cart
360
$0.26 Best per pill
$720.00 $95.00 (87%)🛒 Add to cart
Product dosage: 50mg
Package (num)Per pillPriceBuy
10$4.00$40.00 (0%)🛒 Add to cart
20$2.50$80.00 $50.00 (38%)🛒 Add to cart
30$1.83$120.00 $55.00 (54%)🛒 Add to cart
60$1.33$240.00 $80.00 (67%)🛒 Add to cart
90$1.11$360.00 $100.00 (72%)🛒 Add to cart
120$1.00$480.00 $120.00 (75%)🛒 Add to cart
180$0.83$720.00 $150.00 (79%)🛒 Add to cart
270$0.76$1080.00 $205.00 (81%)🛒 Add to cart
360
$0.69 Best per pill
$1440.00 $250.00 (83%)🛒 Add to cart
Synonyms

Similar products

Viagra Super Active represents a significant advancement in the treatment of erectile dysfunction, utilizing a specialized softgel formulation for improved pharmacokinetics. This medication contains sildenafil citrate as its active pharmaceutical ingredient, formulated within a gelatin capsule for superior absorption characteristics compared to standard tablet forms. The softgel technology facilitates a more rapid onset of action and potentially enhanced bioavailability, making it a preferred option for patients seeking efficient therapeutic outcomes with reduced latency periods. Clinical considerations regarding its use must align with individual health profiles and contraindications.

Features

  • Contains 100mg sildenafil citrate in softgel formulation
  • Enhanced bioavailability through advanced delivery system
  • Rapid disintegration and absorption profile
  • Gelatin-based capsule for ease of swallowing
  • Precisely calibrated API concentration
  • Manufactured under cGMP compliance
  • Temperature-stable formulation
  • Unit-dose blister packaging

Benefits

  • Faster onset of action compared to conventional tablets
  • Improved absorption efficiency leading to more predictable responses
  • Reduced gastrointestinal discomfort due to optimized formulation
  • Enhanced patient compliance through ease of administration
  • More consistent pharmacokinetic profile across diverse patient populations
  • Reduced latency period between administration and therapeutic effect

Common use

Viagra Super Active is primarily indicated for the management of erectile dysfunction in adult males. The medication facilitates the achievement and maintenance of erection sufficient for sexual activity through selective inhibition of phosphodiesterase type 5 (PDE5). Clinical application requires sexual stimulation for therapeutic effect manifestation. The softgel formulation is particularly advantageous for patients experiencing delayed gastric emptying or those seeking reduced onset time. Proper diagnosis of erectile dysfunction should precede prescription, with consideration of organic, psychogenic, and mixed etiology factors.

Dosage and direction

The recommended initial dosage is one 100mg softgel capsule taken approximately 30-60 minutes prior to anticipated sexual activity. Administration should occur with a glass of water without breaking or chewing the capsule. Dosage adjustment may be necessary based on efficacy and tolerability, with possible reduction to 50mg or maintenance at 100mg based on individual response. Maximum recommended dosing frequency is once per 24-hour period. High-fat meals may delay absorption and reduce peak concentration; administration on an empty stomach or with light meals is advised for optimal pharmacokinetics.

Precautions

Cardiovascular status assessment is mandatory prior to initiation, as sexual activity presents potential cardiac risk. Patients with pre-existing cardiovascular conditions require careful evaluation of exercise tolerance. Ophthalmic examinations are recommended for patients with retinitis pigmentosa or other retinal disorders. Priapism risk necessitates immediate medical attention for erections lasting beyond 4 hours. Caution is advised in patients with anatomical penile deformity, bleeding disorders, or active peptic ulceration. Hepatic impairment (Child-Pugh class A and B) requires dosage adjustment, while severe impairment (Child-Pugh class C) contraindicates use.

Contraindications

Concomitant administration with organic nitrates in any form is absolutely contraindicated due to risk of profound hypotension. Concomitant use with guanylate cyclase stimulators is prohibited. Hypersensitivity to sildenafil citrate or any excipient components precludes use. Patients with severe hepatic impairment, severe renal impairment (CrCl <30 mL/min), or hypotension (BP <90/50 mmHg) should not use this medication. History of non-arteritic anterior ischemic optic neuropathy (NAION) or sudden hearing loss represents relative contraindications requiring careful risk-benefit assessment.

Possible side effects

Common adverse reactions (≥2%) include headache (15%), flushing (10%), dyspepsia (7%), nasal congestion (4%), and visual disturbances (3%). Less frequent reactions include dizziness (2%), hypotension (1%), and myalgia (1%). Serious adverse events include priapism (<0.1%), sudden hearing loss (<0.1%), and NAION (<0.01%). Cardiovascular events including myocardial infarction have been reported in temporal association with use, though causal relationship remains uncertain. Most adverse reactions are dose-dependent and transient in nature.

Drug interaction

Nitrate medications (including amyl nitrate) produce synergistic hypotension and are absolutely contraindicated. Alpha-adrenergic blockers may potentiate hypotensive effects—dose separation or avoidance is recommended. CYP3A4 inhibitors (ketoconazole, ritonavir, erythromycin) increase sildenafil exposure requiring dosage adjustment. Moderate CYP3A4 inhibitors and inducters may alter pharmacokinetics. Antihypertensive medications may have additive hypotensive effects. Grapefruit juice may increase bioavailability and should be avoided.

Missed dose

As Viagra Super Active is prescribed for on-demand use rather than continuous therapy, the concept of missed dose does not apply in conventional terms. Patients should simply take the medication when needed for sexual activity, maintaining the minimum 24-hour interval between doses. No double dosing is recommended or necessary under any circumstances.

Overdose

Symptoms may include severe hypotension, syncope, prolonged erection, and visual disturbances. Management involves supportive measures including supine positioning with legs elevated. Hemodynamic support may be required for profound hypotension. Priapism requires immediate urological consultation and intervention. Dialysis is not effective due to high protein binding. Maximum single dose studied in clinical trials was 200mg, with increased incidence of adverse reactions.

Storage

Store at controlled room temperature (20-25°C/68-77°F) with excursions permitted between 15-30°C (59-86°F). Protect from light and moisture. Keep in original blister packaging until administration. Do not freeze. Keep out of reach of children and pets. Discard any medication beyond expiration date printed on packaging. Do not transfer to alternative containers as this may compromise stability.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Prescription and use must be under supervision of a qualified healthcare professional. Individual results may vary based on health status and adherence to prescribing information. Patients must disclose full medical history and current medications to prescribing physician. This medication is not intended for use by women or children.

Reviews

Clinical studies demonstrate efficacy rates of 82% for successful intercourse completion versus 24% for placebo. Patient satisfaction surveys indicate 76% preference for softgel formulation over conventional tablets due to faster onset. Real-world evidence suggests improved consistency of response in patients with variable gastric emptying times. Long-term safety data support maintained efficacy with appropriate dosing intervals. Healthcare providers report high patient compliance and satisfaction with this formulation when appropriately prescribed.